Security key
690469101
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 146,457,154
- Total 13F shares
- 46,326,650
- Share change
- -3,085,427
- Total reported value
- $54,661,169
- Put/Call ratio
- 1.3%
- Price per share
- $1.18
- Number of holders
- 75
- Value change
- -$2,312,497
- Number of buys
- 37
- Number of sells
- 23
Report period
Q3 2024
Institutions
75
Top holders
10
OVID full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Ovid Therapeutics Inc. SEC filings
Ovid Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 690469101
Recent filing periods:
Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
5.1%
|
7,531,996
|
$5,792,461 | — | 30 Jun 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
3.6%
|
5,315,969
|
$4,089,043 | — | 30 Jun 2024 | |
| Madison Avenue Partners, LP |
13F
|
Company |
2.8%
|
4,082,100
|
$3,139,951 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.7%
|
3,992,346
|
$3,070,913 | — | 30 Jun 2024 | |
| BVF INC/IL |
13F
|
Company |
2.6%
|
3,853,818
|
$2,964,357 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
3,089,393
|
$2,376,361 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
1.7%
|
2,500,000
|
$1,923,000 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,664,552
|
$1,279,000 | — | 30 Jun 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,488,571
|
$1,145,009 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1%
|
1,466,433
|
$1,127,980 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.96%
|
1,400,191
|
$1,077,027 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.92%
|
1,354,371
|
$1,041,782 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.89%
|
1,302,514
|
$1,002,007 | — | 30 Jun 2024 | |
| TLS Advisors LLC |
13F
|
Company |
0.77%
|
1,125,296
|
$866,000 | — | 30 Jun 2024 | |
| Prosight Management, LP |
13F
|
Company |
0.73%
|
1,075,000
|
$826,890 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.51%
|
741,640
|
$570,469 | — | 30 Jun 2024 | |
| FFT WEALTH MANAGEMENT LLC |
13F
|
Company |
0.33%
|
489,552
|
$376,563 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.32%
|
465,532
|
$358,087 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
352,170
|
$270,889 | — | 30 Jun 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.2%
|
288,290
|
$221,695 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.19%
|
274,982
|
$211,372 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
218,163
|
$167,811 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
161,808
|
$124,463 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
141,200
|
$108,611 | — | 30 Jun 2024 | |
| Empowered Funds, LLC |
13F
|
Company |
0.09%
|
137,970
|
$106,127 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
126,826
|
$97,555 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.08%
|
119,507
|
$92,000 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.08%
|
119,113
|
$91,622 | — | 30 Jun 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.08%
|
115,832
|
$89,098 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
105,177
|
$80,986 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.07%
|
98,590
|
$75,836 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.05%
|
78,024
|
$60,016 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
69,733
|
$53,617 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
68,950
|
$53,035 | — | 30 Jun 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
0.05%
|
68,517
|
$52,703 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
47,880
|
$36,829 | — | 30 Jun 2024 | |
| DCF Advisers, LLC |
13F
|
Company |
0.03%
|
41,750
|
$32,114 | — | 30 Jun 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.02%
|
31,683
|
$24,371 | — | 30 Jun 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.02%
|
31,039
|
$23,875 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
30,913
|
$23,778 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
29,534
|
$22,712 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
28,850
|
$22,192 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.02%
|
26,154
|
$20,118 | — | 30 Jun 2024 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0.02%
|
26,000
|
$19,999 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
21,192
|
$16,297 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
20,473
|
$15,748 | — | 30 Jun 2024 | |
| David M. Knott Jr. |
13F
|
Individual |
0.01%
|
20,000
|
$15,000 | — | 30 Jun 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.01%
|
19,190
|
$14,761 | — | 30 Jun 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
18,986
|
$14,604 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.01%
|
17,396
|
$14,000 | — | 30 Jun 2024 |
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q3 2024
As of 30 Sep 2024,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,326,650 shares.
The largest 10 holders included
TAKEDA PHARMACEUTICAL CO LTD, Rubric Capital Management LP, BlackRock, Inc., Madison Avenue Partners, LP, BVF INC/IL, VANGUARD GROUP INC, Siren, L.L.C., ACADIAN ASSET MANAGEMENT LLC, KENNEDY CAPITAL MANAGEMENT LLC, and JPMORGAN CHASE & CO.
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
72
Q3 2024 holders
75
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.